Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VE303 in Hepatic Encephalopathy
NCT04899115Phase 2Completed
- Start
- Aug 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
A Phase 2 trial of VE303 in hepatic encephalopathy (HE). Started Aug 2021; status: completed.
02
Drugs
VE303
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT04899115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04899115.